Diamedica Therapeutics Inc. · NASDAQ:DMAC

Trill AB reported a 13.14% stake in Diamedica Therapeutics Inc. (Schedule 13G/A)

Event Jul 23, 2025 · Filed Jul 30, 2025

Trill AB reported a 13.14% stake in Diamedica Therapeutics Inc., 6,764,465 shares, as a passive investor on Jul 23, 2025. Filed Jul 30, 2025 (Schedule 13G/A).

Stake
13.14%
Shares
6,764,465
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Trill AB13.14%6,764,465
Jan Stahlberg13.14%6,764,465

Source

View original at SEC

Related